United Therapeutics Corp. (UTHR)
473.12
-3.01
(-0.63%)
USD |
NASDAQ |
Feb 13, 16:00
473.12
0.00 (0.00%)
After-Hours: 16:57
United Therapeutics Free Cash Flow : 1.116B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics, Inc. | 162.57M |
| Gilead Sciences, Inc. | 10.02B |
| Johnson & Johnson | 19.70B |
| Catalyst Pharmaceuticals, Inc. | 234.54M |
| MannKind Corp. | 42.74M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 562.10M |
| Cash from Investing (Quarterly) | 140.90M |
| Cash from Financing (Quarterly) | -956.00M |
| Free Cash Flow Per Share (Quarterly) | 7.317 |
| Free Cash Flow to Equity (Quarterly) | 346.10M |
| Free Cash Flow to Firm (Quarterly) | 348.42M |
| Free Cash Flow Yield | 4.89% |